Exciting new findings in UT’s neurobiology labs suggest that rapamycin, an FDA-approved immunosuppressant used to control organ rejection in transplant patients, may be an effective therapy for Alzheimer’s, epilepsy, and even autism. Now a UT team led by Professor Kim Raab-Graham of the College of Natural Sciences‘ Center for Learning and Memory is searching for an equivalent drug that can deliver the benefit without the side effects.
Jul 08, 2012
Old Drug Holds New Promise
Exciting new findings in UT’s neurobiology labs suggest that rapamycin, an FDA-approved immunosuppressant used to control organ rejection in transplant patients, may be an effective therapy for Alzheimer’s, epilepsy, and even autism.
